DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Stallmach A, Langbein C, Atreya R. et al.
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study.

Aliment Pharmacol Ther 2016;
44: 1199-1212

Stallmach A, Langbein C, Atreya R. et al.
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study.

Aliment Pharmacol Ther 2016;
44: 1199-1212

Download Bibliographical Data

Search in:
Access: